NewcelX Ltd.

NewcelX Ltd. (ticker: NCEL) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of NCEL's SEC filings surfaces 6 active risk signals, including 4 late-filing signals, and 2 auditor-change signals. NCEL reported no tagged revenue in revenue and -$8.30M for the period ending 2025-12-31, with operating cash flow of -$2.77M. Cash and equivalents stood at $2.20M (up 238.6% year-over-year). Total assets of $11.45M exceed total liabilities of $4.20M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.